Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Canadian Nuclear Isotope Council (CNIC) is an independent, not-for-profit advocacy and member services organization representing over 130 science, academia, healthcare, and nuclear-sector organizations. Established in 2018, the CNIC is dedicated to maintaining and advancing Canada's position as a global leader in the production of life-saving medical isotopes and radiopharmaceuticals. The council advocates for long-term, science-based public policies that support healthcare innovation, safeguard the isotope supply chain, and drive economic growth. Through initiatives like the 'Isotopes for Hope' campaign, the CNIC works to double domestic isotope production by 2030 to meet the rising global demand for precision cancer therapies and diagnostic imaging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canadian Nuclear Isotope Council.